Clinical Trials Browser

Graft vs Host Disease × fludarabine × 90 days × Clear all

NCT06252870 2026-01-26

CY-MET-RIC

Phase 2 Recruiting

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT03983850 2025-12-26

Optimizing PTCy Dose and Timing

Phase 1/2 Active not recruiting

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms